Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil PCA with fascia iliaca block after total hip arthroplasty in frail elderly
ChiCTR2500112429Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Composite incidence of adverse reactions within 48 hours. Started Nov 2025; status: recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500112429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112429.